• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

133
21
15
11
4

COUNTRY

7
4
4
3
2

PRICE

58
99
130
252

PUBLISHED

6
11
27
252

PRODUCT TYPE

233
16
3

Drug Discovery

Bringing a new medicine to market is a process that cost about $1bn and can take up to 15 years. With the pharmaceutical industry facing multiple crises, budgets for research being squeezed and tough scientific challenges looming, academics and patients' groups are concerned we will not have the drugs necessary to treat future ills. More challenges will be posed by the imminent expiry of patents for some of the most lucrative drugs. The old model of drug discovery seems to be no longer efficient.

What is the future scenario of R&D? Keep track of the latest developments, trends and issues in this crucial sector of the huge pharmaceuticals industry with the publications listed under Research and Markets’ Drug Discovery category. You will find a wide range of academic and scientific textbooks on the latest R&D techniques, as well as top quality market reports with historical data and forecasts. Show Less
Read more

PRODUCT TITLE

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition

Kalorama Information's Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size,...

June 2010
FROM
Ion Channels: Key Therapeutic Targets Ion Channels: Key Therapeutic Targets - Product Thumbnail Image

Ion Channels: Key Therapeutic Targets

This Special Focus Issue of the peer-reviewed journal Future Medicinal Chemistry provides a comprehensive, forward-looking overview of topical themes and recent advances in the field of ion channel-based...

May 2010
FROM
The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers - Product Thumbnail Image

The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers

In recent years, industrial and pharmaceutical companies have increased the amount of services they outsource to contract research organizations (CROs) This report will address whether CROs that service...

April 2010
FROM
Microdosing: Special Focus Microdosing: Special Focus - Product Thumbnail Image

Microdosing: Special Focus

This Special Focus Issue of the peer-reviewed journal Bioanalysis on microdosing collates data and experience of experts and thought leaders in the field of drug discovery and development and places...

March 2010
FROM

Lab Automation Markets, 2nd Edition (Systems, Key Companies, Forecasts and Trends)

This report, Lab Automation Markets analyzes the current and potential world markets for medical laboratory automation systems and equipment - both for clinical diagnostics and drug discovery research...

March 2010
FROM

Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs

“Biomarkers In Drug Discovery - Optimizing Drug Discovery Timeline and Costs” The report provides an in-depth analysis of the potential applications of biomarkers in pharmaceutical drug discovery and...

February 2010
FROM

Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption

“Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provides Impetus for RFID Adoption ” provides key data and analysis of the major factors affecting the market...

February 2010
FROM
Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access - Product Thumbnail Image

Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access

A major new report Orphan Drugs in Asia-Pacific: From designation to pricing, funding and market access focuses on five developed markets in the region: Japan, South Korea, Taiwan, Singapore and Australia...

February 2010

Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting

“Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting ” provides key data, information and analysis of the major trends and issues affecting the drug discovery...

February 2010
FROM
Frontiers in CNS Drug Discovery Volume 1 Frontiers in CNS Drug Discovery Volume 1 - Product Thumbnail Image

Frontiers in CNS Drug Discovery Volume 1

“Frontiers in CNS Drug Discovery” is an Ebook series devoted to publishing the latest and the most important advances in Central Nervous System (CNS) drug design and discovery. Eminent scientists write...

January 2010
Frontiers in Cardiovascular Drug Discovery Volume 1 Frontiers in Cardiovascular Drug Discovery Volume 1 - Product Thumbnail Image

Frontiers in Cardiovascular Drug Discovery Volume 1

“Frontiers in Cardiovascular Drug Discovery” is an Ebook series devoted to publishing the latest and the most important advances in Cardiovascular drug design and discovery. Eminent scientists write...

January 2010

The Future of eClinical Trial Solutions – Market Forecasts to 2015, Competitive Benchmarking and Case Studies

“The Future of e-Clinical Trial Solutions - Market Forecasts to 2015, Competitive Benchmarking and Case Studies” which provides key data and analysis of the major factors affecting the market for e-Clinical...

December 2009
FROM
Competitor Analysis: Proteasome Inhibitors Competitor Analysis: Proteasome Inhibitors - Product Thumbnail Image

Competitor Analysis: Proteasome Inhibitors

The present Competitive Intelligence Report about Proteasome Inhibitors provides a competitor evaluation in the field of novel small molecules and peptides targeting the proteasome for treatment of...

November 2009
FROM
Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO) Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO) - Product Thumbnail Image

Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO)

The Competitive Intelligence Report Thrombopoiesis Stimulating Agents (TPO, IL-11) as of November 2009 provides information on thrombopoiesis stimulating agents targeting the thrombopoietin, interleukin-11...

November 2009
FROM
Competitor Analysis: PDGF-R Agonists and Antagonists Competitor Analysis: PDGF-R Agonists and Antagonists - Product Thumbnail Image

Competitor Analysis: PDGF-R Agonists and Antagonists

The present Competitive Intelligence Report about PDGF-R agonists and antagonists provides a competitor evaluation in the field of platelet derived growth factor receptor (PDGF-R) or PDGF targeting...

October 2009
FROM
Blood-Brain Barrier Blood-Brain Barrier - Product Thumbnail Image

Blood-Brain Barrier

It is extremely difficult to treat CNS diseases because most therapeutics do not readily cross from the blood into the brain and spinal cord due to the ‘blood–brain barrier’ This Special Focus Issue...

October 2009
FROM

The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)

The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they...

October 2009
FROM
Prospects for the Phase III Bapineuzumab Trial Prospects for the Phase III Bapineuzumab Trial - Product Thumbnail Image

Prospects for the Phase III Bapineuzumab Trial

One of the most watched clinical trials is the phase III trial for bapineuzumab, a humanized monoclonal antibody designed to bind to and remove Aß in the blood and in the brain Concerns have arisen...

September 2009
Peripheral Neuropathy and Neuropathic Pain 2008 Peripheral Neuropathy and Neuropathic Pain 2008 - Product Thumbnail Image

Peripheral Neuropathy and Neuropathic Pain 2008

This report estimates that Peripheral Neuropathy (PN) and Neuropathic Pain (NP) affect 170 to 270 million individuals globally PN and NP are causally linked to a number of diseases, however diabetes,...

June 2009
FROM

Pharmacogenomics for Clinical Use and in Drug Development

Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth Applying pharmacogenomics would...

June 2009
FROM
Loading Indicator

Our Clients

Our clients' logos